Manufacturers

Exploring the evolving landscape of cell and gene therapies: Insights from Pharma USA 2024

Manufacturers

Opportunities and pain points for CGT innovation and market access

Our global advanced therapy medical product charging stations and capabilities

Infographic: Exploring the landscape, modalities, and logistics of cell and gene therapies

Manufacturers

Streamlining Patient Access to Cell and Gene Therapies

Manufacturers

Avoiding CGT commercialization pitfalls

Manufacturers

Q&A – How the tendency towards decentralized supply chains has changed in CGT

Manufacturers

Cell and gene therapy trials — The synergy of CRO and specialty logistics collaboration

Manufacturers

Valuing potential cures: An examination of ICER’s approach to assessing high-impact single and short-term therapies

Manufacturers

Advancing Cell and Gene Therapy (CGT) Access: Insights from CAR-TCR 2023

Q&A – Future challenges and predictions for CGT patient focused solutions

Manufacturers

Podcast: Industry led product development in a rapidly changing CGT landscape

Manufacturers

Podcast: The future is bright; the future is CGT

Manufacturers

Report: Creating a sustainable business model for cell and gene therapies

Manufacturers

How innovations in cryologistics support patient access to advanced therapies

Manufacturers

Improving Access and Support for Cell and Gene Therapies

Manufacturers

Q&A: The evolution of the cell and gene therapy field

Manufacturers

Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference

Manufacturers

Three opportunities and three challenges in the cell and gene therapy market

Manufacturers

Recap AMCP 2023: Our thought leadership in action

Delivering advanced CGT biologic breakthroughs to the world

Infographic: How cryogenic logistics overcome the low tolerance for deviations of cell and gene therapies

Why location monitoring matters: Amelia's journey with spinal muscular atrophy (SMA)

Evolving advanced therapy medicinal product regulations require new logistics complexity

Regulators tightening cell and gene therapies logistics controls to assure patient safety and security

Time to adapt Europe’s evolving cell and gene therapy regulatory framework before it prevents patient access due to logistics hurdles

Manufacturers

Three questions biopharma companies must ask when building a cell and gene commercialization strategy

Manufacturers

In conversation with TrakCel: Why successful partnerships can help accelerate advanced therapies

Manufacturers

Interview: Increasing advanced therapies’ connectivity and speed to market through partnership

With landmark approval, spotlight on cryogenic logistics intensifies

Manufacturers

Webinar: Evaluate alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

Preserving cell and gene integrity in the supply chain

Manufacturers

Evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

Cold hard facts about cryogenic cell and gene therapy logistics

Fresh or frozen - understanding the supply chain needs of your cell and gene therapy

Manufacturers

Alternate payer engagement models are changing the landscape

Manufacturers

Navigating reimbursement and access challenges for novel cell and gene therapies

Round table recording: To freeze or not to freeze - challenges and innovations in cell therapy logistics

Manufacturers

Getting the right drug to the right patient at the right place at the right time

Manufacturers

Webinar slides: Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies

Report: Building successful cell and gene therapy supply chains

Podcast: Emerging cell and gene therapies, complex logistics eco-systems, and the need for greater industry collaboration

The time is now: why it pays to be prepared for the commercialization of advanced therapies

Manufacturers

Managing clinical supply chain complexity for cell and gene therapies

Manufacturers

How to optimize the commercial supply chain for cell and gene therapies

White paper: Setup a robust and scalable supply chain for Cell and Gene Therapies

Manufacturers

Webinar: Key insights on the clinical to commercial transition for autologous therapies

Manufacturers

Webinar: Commercial supply chain strategies for cell and gene therapies

Manufacturers

Webinar | Cell and gene therapies: Clinical supply chain considerations

Manufacturers

What manufacturers need to know about reimbursement and patient support for cell and gene therapies

Video: How to build a cryogenic logistics platform for allogeneic therapies

Manufacturers

On-demand webinar: Success factors for commercializing rare disease and orphan drugs

Manufacturers

On demand webinar: Considerations for the commercialization of cell and gene therapies

Case study: "The last 100m" - Managing the logistics of advanced therapies in an acute NHS hospital setting

Webinar on-demand: Partnering in a pandemic, a case study by World Courier and Pluristem

Manufacturers

Cell and gene therapies: bringing innovation to market

Whitepaper: Key Strategies for Cell and Gene Therapy in China

E-book: Delivering innovation, improving lives

Article: Advanced Therapy Commercial Supply Chain Lessons for Clinical Trial Success

Manufacturers

The Supply Chain Redefined: Cell and Gene Therapies

Manufacturers

Financial Management for Cell and Gene Therapies

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Manufacturers

Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

Manufacturers

Rethinking Reimbursement and Patient Support Following Medical Innovation

Manufacturers

Logistics Decisions Will Impact the Success of New Cell and Gene Therapies

Manufacturers

Commercializing Cell and Gene Therapies